Biohaven Ltd. (BHVN)
11.14
+0.07
(+0.63%)
USD |
NYSE |
Jun 11, 11:15
Biohaven Accounts Payable (Quarterly) : 10.42M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 10.42M |
| December 31, 2025 | 11.64M |
| September 30, 2025 | 17.49M |
| June 30, 2025 | 19.63M |
| March 31, 2025 | 19.14M |
| December 31, 2024 | 18.03M |
| September 30, 2024 | 19.74M |
| June 30, 2024 | 17.26M |
| Date | Value |
|---|---|
| March 31, 2024 | 36.38M |
| December 31, 2023 | 15.58M |
| September 30, 2023 | 9.515M |
| June 30, 2023 | 12.04M |
| March 31, 2023 | 14.46M |
| December 31, 2022 | 10.70M |
| September 30, 2022 | 4.731M |
| June 30, 2022 | 0.00 |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| NovelStem International Corp. | 0.00 |
| Brainstorm Cell Therapeutics, Inc. | 7.317M |
| Summit Therapeutics, Inc. | 27.55M |
| Kezar Life Sciences, Inc. | 0.273M |
| Protara Therapeutics, Inc. | 4.031M |